Oligodendrocyte Maturation Alters the Cell Death Mechanisms That Cause Demyelination
Open accessPublished version of a preprint
Abstract
Myelinating oligodendrocytes die in human disease and early in aging. Despite this, the mechanisms that underly oligodendrocyte death are not resolved and it is also not clear whether these mechanisms change as oligodendrocyte lineage cells are undergoing differentiation and maturation. Here, we used a combination of intravital imaging, single-cell ablation, and cuprizone-mediated demyelination, in both female and male mice, to discover that oligodendrocyte maturation dictates the dynamics and mechanisms of cell death. After single-cell phototoxic damage, oligodendrocyte precursor cells underwent programmed cell death within hours, differentiating oligodendrocytes died over several days, while mature oligodendrocytes took weeks to die. Importantly cells at each maturation stage all eventually died but did so with drastically different temporal dynamics and morphological features. Consistent with this, cuprizone treatment initiated a caspase-3–dependent form of rapid cell death in differentiating oligodendrocytes, while mature oligodendrocytes never activated this executioner caspase. Instead, mature oligodendrocytes exhibited delayed cell death which was marked by DNA damage and disruption in poly-ADP-ribose subcellular localization. Thus, oligodendrocyte maturation plays a key role in determining the mechanism of death a cell undergoes in response to the same insult. This means that oligodendrocyte maturation is important to consider when designing strategies for preventing cell death and preserving myelin while also enhancing the survival of new oligodendrocytes in demyelinating conditions.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
BCAS1 + GFP+ oligodendrocytes represent a relatively more mature differentiating oligodendrocyte state than BCAS1 + GFP- cells.
“BCAS1 + GFP+ oligodendrocytes should represent a relatively more mature differentiating oligodendrocyte state than BCAS1 + GFP‐ cells (Chapman et al. 2024; Hughes et al. 2018; Orthmann‐Murphy et al. 2020).”
From Depletion of Microglia Increases Cortical Oligodendrocyte Density During Remyelination (2026) · cites this paper as Chapman et al. 2024
BCAS1 is expressed by newly differentiated, pre-myelinating, and early-myelinating oligodendrocytes that derive from NG2+ OPCs but do not yet express all mature oligodendrocyte markers.
“Recent studies showed that BCAS1 (breast carcinoma amplified sequence 1) is expressed by a subset of the oligodendrocyte lineage: newly differentiated, pre‐myelinating, and early‐myelinating oligodendrocytes that derive from NG2+ OPCs but do not yet express all mature oligodendrocyte markers (Chapman et al. 2024; Fard et al. 2017).”
From Depletion of Microglia Increases Cortical Oligodendrocyte Density During Remyelination (2026) · cites this paper as Chapman et al. 2024
BCAS1+ cells die by a caspase-3 dependent mechanism.
“Most of these differentiating cells likely died by apoptosis; BCAS1+ cells were recently shown to die by a caspase‐3 dependent mechanism (Chapman et al. 2024).”
From Depletion of Microglia Increases Cortical Oligodendrocyte Density During Remyelination (2026) · cites this paper as Chapman et al. 2024
The early oligodendrocyte cell population may rapidly mobilize to compensate for oligodendrocyte loss following cuprizone administration, but the continued presence of cuprizone precludes the survival and maturation of the new oligodendrocytes.
“Together, these findings indicate that the early oligodendrocyte cell population may rapidly mobilize to compensate for the oligodendrocyte loss following cuprizone administration, but the continued presence of cuprizone precludes the survival and maturation of the new oligodendrocytes [42].”
From Multifaceted response of microglia in the cuprizone model of demyelination (2026) · cites this paper as [42]
The citation lists haven’t been fetched yet
References 85 · Cited by 33
- Authors
- Chapman, T. W., Kamen, Y., Piedra, E. T., & Hill, R. A.
- Affiliations
- Dartmouth College (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2024-02-23
- Volume
- 44
- Issue
- 13
- Pages
- e1794232024
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC10977033
- OpenAlex
- W4392094192
- Cited by
- 33
- References
- 85
- Citations by year
- 2026: 16 · 2025: 11 · 2024: 6
- FWCI
- 5.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- HHS | NIH | National Institute of Neurological Disorders and Stroke (R01NS122800)
- Esther A. and Joseph Klingenstein Fund
- Topics
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
- Keywords
- oligodendrocyte maturation, demyelination, oligodendrocyte death, programmed cell death, cuprizone, caspase-3, DNA damage, poly(ADP-ribose), oligodendrocyte precursor cells, myelination, intravital imaging
- MeSH terms
- Animals, Cell Differentiation, Cuprizone, Demyelinating Diseases, Female, Humans, Male, Mice, Inbred C57BL, Myelin Sheath, Oligodendroglia, Apoptosis, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review